New Results
Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19
Jing Xing, Rama Shankar, Aleksandra Drelich, Shreya Paithankar, Eugene Chekalin, Thomas Dexheimer, Surender Rajasekaran, Chien-Te Kent Tseng, Bin Chen
doi: https://doi.org/10.1101/2020.04.07.030734
Jing Xing
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
Rama Shankar
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
Aleksandra Drelich
2Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA
Shreya Paithankar
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
Eugene Chekalin
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
Thomas Dexheimer
3Department of Pharmacology and Toxicology, Michigan State University, Grand Rapids, Michigan, USA
Surender Rajasekaran
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
4Helen Devos Children Hospital, Grand Rapids, Michigan, USA
Chien-Te Kent Tseng
2Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA
5Center of Biodefense and Emerging Disease, University of Texas Medical Branch, Galveston, Texas, USA
Bin Chen
1Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, Michigan, USA
3Department of Pharmacology and Toxicology, Michigan State University, Grand Rapids, Michigan, USA
Article usage
Posted April 09, 2020.
Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19
Jing Xing, Rama Shankar, Aleksandra Drelich, Shreya Paithankar, Eugene Chekalin, Thomas Dexheimer, Surender Rajasekaran, Chien-Te Kent Tseng, Bin Chen
bioRxiv 2020.04.07.030734; doi: https://doi.org/10.1101/2020.04.07.030734
Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19
Jing Xing, Rama Shankar, Aleksandra Drelich, Shreya Paithankar, Eugene Chekalin, Thomas Dexheimer, Surender Rajasekaran, Chien-Te Kent Tseng, Bin Chen
bioRxiv 2020.04.07.030734; doi: https://doi.org/10.1101/2020.04.07.030734
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)